Paracetamol Mabo

Paracetamol, the active ingredient in Paracetamol Mabo, is an analgesic presented as an oral tablet for oral use. It provides relief from mild to moderate pain and reduces fever in adults and children when appropriate. It is widely used in primary care and over‑the‑counter settings for temporary symptom management.

GNH USA supplies Paracetamol Mabo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance across all markets. The company adheres to stringent quality standards and provides reliable logistics support for global distribution.

Paracetamol is an analgesic/antipyretic that acts on the prostaglandin pathway to relieve pain and reduce fever. - Headache: alleviates mild to moderate headache pain. - Fever: lowers elevated body temperature in adults and children. - Musculoskeletal pain: reduces discomfort from strains, sprains, and backache. - Dental pain: eases pain associated with toothache and dental procedures.

Paracetamol is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Nausea: mild stomach upset that may occur after ingestion. - Rash: occasional skin irritation or mild allergic reaction. - Headache: paradoxical headache in a small number of users. - Dizziness: transient light‑headedness reported by some patients. - Elevated liver enzymes: mild, usually reversible increase in hepatic enzymes.

Serious or Rare Side Effects: - Stevens‑Johnson syndrome: severe skin reaction requiring immediate medical attention. - Toxic hepatitis: potentially life‑threatening liver injury. - Agranulocytosis: rare reduction in white blood cells. - Anaphylaxis: acute allergic reaction with breathing difficulty. - Severe skin reactions: such as toxic epidermal necrolysis. - Blood disorders: rare cases of thrombocytopenia or hemolytic anemia.

Paracetamol should be used with caution in specific populations and clinical situations. - Dosage adjustment: reduce dose in patients with hepatic impairment. - Alcohol use: avoid excessive alcohol consumption while taking the product. - Pregnancy: use only if clearly needed and after medical advice. - Age: caution in children under two years unless prescribed. - Concomitant hepatotoxic drugs: monitor liver function when combined with other hepatotoxic agents. - Store below 25°C: keep in the original pack, protect from moisture.

Paracetamol may interact with several medicines; some interactions require avoidance while others need monitoring.

Major Interactions (Avoid): - Warfarin: may increase anticoagulant effect, monitor INR closely. - Isoniazid: risk of hepatotoxicity increases. - Carbamazepine: may reduce paracetamol clearance, leading to toxicity.

Moderate Interactions (Monitor Closely): - Alcohol: combined use can heighten liver injury risk. - Other hepatotoxic drugs: such as certain antituberculars, monitor liver enzymes. - Enzyme inducers: e.g., rifampicin may lower paracetamol plasma levels.